CLINDACIN

This brand name is authorized in Ecuador, United States

Active ingredients

The drug CLINDACIN contains one active pharmaceutical ingredient (API):

1 Clindamycin UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. Read about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLINDACIN Foam	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G01AA10	Clindamycin	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 02775-MAN-09-03
Country: US	FDA, National Drug Code	Identifier(s): 43538-170, 43538-171, 43538-172, 43538-179